Table 3. . Performance of model for end-stage liver disease-Na-metabolite models versus model for end-stage liver disease-Na score to predict 1-year mortality in patients with cirrhosis caused by primary biliary cholangitis or primary sclerosing cholangitis.
| MELD-Na Score | Plasma metabolites | Hazard ratio for MELD-Na score† | p-value for hazard ratio for MELD-Na score | Hazard ratio for metabolite† | p-value for hazard ratio for metabolite | Time-dependent AUROC (at year)‡ | AUROCC 95% confidence limits (lower)§ | AUROCC 95% confidence limits (upper)§ | |
|---|---|---|---|---|---|---|---|---|---|
| MELD-Na score | + | Myo-inositol | 1.091 | 0.1104 | 3.139 | 0.0356 | 0.9392 | 0.5804 | 1.0000 |
| MELD-Na score | + | N6-Acetyllysine | 1.204 | 0.0026 | 0.508 | 0.2777 | 0.9023 | 0.7442 | 1.0000 |
| MELD-Na score | + | N-Acetylalanine | 1.052 | 0.4350 | 0.078 | 0.0423 | 0.8653 | 0.1290 | 1.0000 |
| MELD-Na score | + | Gamma-Glutamylphenylanine | 1.163 | 0.0021 | 0.530 | 0.5244 | 0.8574 | 0.1634 | 1.0000 |
| MELD-Na score | + | Adenosine | 1.181 | 0.0018 | 0.722 | 0.0948 | 0.8569 | 0.5918 | 1.0000 |
| MELD-Na score | + | N-Acetylputrescine | 1.135 | 0.0162 | 2.422 | 0.0461 | 0.8426 | 0.6578 | 1.0000 |
| MELD-Na score | + | N6-Carbamoylthreonyladenosine | 1.091 | 0.1253 | 8.962 | 0.0050 | 0.8279 | 0.6246 | 1.0000 |
| MELD-Na score | + | Erythronate | 1.083 | 0.1803 | 4.269 | 0.0468 | 0.8193 | 0.6705 | 0.9681 |
| MELD-Na score | + | 3-Ureidopropionate | 1.190 | 0.0008 | 0.312 | 0.2005 | 0.8190 | 0.3470 | 1.0000 |
| MELD-Na score | + | N2,N2-Dimethylguanosine | 1.105 | 0.0915 | 14.670 | 0.0064 | 0.8055 | 0.5803 | 1.0000 |
| MELD-Na score | + | N1-Methyladenosine | 1.135 | 0.0246 | 5.320 | 0.0632 | 0.7975 | 0.3781 | 1.0000 |
| MELD-Na score | + | N-Acetylvaline | 1.172 | 0.0020 | 0.724 | 0.3344 | 0.7900 | 0.5956 | 0.9844 |
| MELD-Na score | + | S-Adenosylhomocysteine (SAH) | 1.185 | 0.0017 | 3.375 | 0.1941 | 0.7889 | 0.3442 | 1.0000 |
| MELD-Na score | + | Glucuronate | 1.081 | 0.1663 | 3.402 | 0.0138 | 0.7826 | 0.5927 | 0.9724 |
| MELD-Na score | + | Dimethylarginine (SDMA + ADMA)¶ | 1.124 | 0.0355 | 3.257 | 0.0665 | 0.7802 | 0.5775 | 0.9829 |
| MELD-Na score | + | Creatinine | 1.209 | 0.0011 | 5.045 | 0.0157 | 0.7748 | 0.2986 | 1.0000 |
| MELD-Na score | + | Trans-aconitate | 1.149 | 0.0267 | 1.112 | 0.7862 | 0.7741 | 0.6183 | 0.9300 |
| MELD-Na score | + | Picolinate | 1.154 | 0.0035 | 2.130 | 0.2150 | 0.7741 | 0.5740 | 0.9743 |
| MELD-Na score | + | Cystathionine | 1.124 | 0.0398 | 1.418 | 0.3167 | 0.7674 | 0.5597 | 0.9750 |
| MELD-Na score | + | Adenine | 1.177 | 0.0012 | 1.425 | 0.1446 | 0.7671 | 0.5667 | 0.9676 |
| MELD-Na score | + | Xylitol | 1.138 | 0.0097 | 2.081 | 0.3330 | 0.7671 | 0.3421 | 1.0000 |
| MELD-Na score | + | N-Acetylserine | 1.169 | 0.0023 | 1.219 | 0.5192 | 0.7662 | 0.5989 | 0.9335 |
| MELD-Na score | + | Cytidine | 1.152 | 0.0049 | 1.872 | 0.1996 | 0.7594 | 0.5354 | 0.9834 |
| MELD-Na score | + | Pseudouridine | 1.164 | 0.0018 | 0.597 | 0.4666 | 0.7594 | 0.5467 | 0.9721 |
| MELD-Na score | 1.162 | 0.0020 | 0.7591 | 0.5553 | 0.9628 | ||||
| MELD-Na score | + | N4-Acetylcytidine | 1.168 | 0.0074 | 1.040 | 0.8623 | 0.7442 | 0.5877 | 0.9007 |
| MELD-Na score | + | N-Formylmethionine | 1.146 | 0.0075 | 2.062 | 0.4006 | 0.7440 | 0.5339 | 0.9541 |
| MELD-Na score | + | 3-(4-Hydroxyphenyl)lactate | 1.098 | 0.1204 | 1.932 | 0.1702 | 0.7440 | 0.5479 | 0.9400 |
| MELD-Na score | + | 7-Methylguanine | 1.168 | 0.0020 | 2.651 | 0.3461 | 0.7365 | 0.4934 | 0.9796 |
| MELD-Na score | + | 3-Methoxytyramine Sulfate | 1.159 | 0.0026 | 1.255 | 0.7981 | 0.7365 | 0.3450 | 1.0000 |
| MELD-Na score | + | 1-Methylhistidine | 1.137 | 0.0107 | 1.758 | 0.0530 | 0.7358 | 0.5320 | 0.9395 |
| MELD-Na Score | + | Phenyllactate | 1.146 | 0.0071 | 2.881 | 0.3779 | 0.7213 | 0.0924 | 1.0000 |
| MELD-Na score | + | 4-Acetamidobutanoate | 1.142 | 0.0216 | 1.934 | 0.0168 | 0.7126 | 0.5147 | 0.9106 |
| MELD-Na score | + | 3-Methoxtyrosine | 1.105 | 0.0707 | 0.319 | 0.1265 | 0.6883 | 0.4361 | 0.9405 |
Bold font highlights the MELD-Na score.
Metabolites were expressed on a log2 scale - hazard ratios represent the risk of death associated with one log2 unit increment.
Data were sorted by AUROC (largest to smallest), then by p-value (smallest to largest).
CIs that did not include 0.50 were considered significant (e.g., 95% CIs for the AUROC of MELD-Na-myo-inositol model was significant because it did not include 0.50). Several models that combined MELD-Na score with a plasma metabolite predicted 1-year mortality with significantly greater accuracy (AUROC) compared with the accuracy (AUROC) of the MELD-Na score alone.
SDMA; ADMA.
ADMA: Asymmetric dimethylarginine; AUROC: Area under the receiver operating characteristic; MELD-Na: Model for end-stage liver disease-Na; SDMA: Symmetric dimethylarginine.